These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 20943753

  • 1. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
    Jedel E, Labrie F, Odén A, Holm G, Nilsson L, Janson PO, Lind AK, Ohlsson C, Stener-Victorin E.
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E37-45. PubMed ID: 20943753
    [Abstract] [Full Text] [Related]

  • 2. Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
    Stener-Victorin E, Baghaei F, Holm G, Janson PO, Olivecrona G, Lönn M, Mannerås-Holm L.
    Fertil Steril; 2012 Feb; 97(2):501-8. PubMed ID: 22154367
    [Abstract] [Full Text] [Related]

  • 3. Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome.
    Stener-Victorin E, Waldenström U, Tägnfors U, Lundeberg T, Lindstedt G, Janson PO.
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):180-8. PubMed ID: 10716298
    [Abstract] [Full Text] [Related]

  • 4. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA, Shin SY, Yoon BK, Choi D.
    Gynecol Endocrinol; 2007 Mar; 23(8):461-7. PubMed ID: 17852414
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B, Slopien R, Warenik-Szymankiewicz A.
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [Abstract] [Full Text] [Related]

  • 8. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 9. Polycystic ovary syndrome: a common but often unrecognized condition.
    Shannon M, Wang Y.
    J Midwifery Womens Health; 2012 Jul; 57(3):221-30. PubMed ID: 22594862
    [Abstract] [Full Text] [Related]

  • 10. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH.
    Am J Epidemiol; 2008 Aug 01; 168(3):321-8. PubMed ID: 18550559
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U, Ezeh C, Pisarska MD, Azziz R.
    Fertil Steril; 2021 Jun 01; 115(6):1557-1568. PubMed ID: 33602559
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ, Saxena T, Lobo RA.
    J Steroid Biochem Mol Biol; 2014 Jan 01; 139():73-7. PubMed ID: 24121067
    [Abstract] [Full Text] [Related]

  • 14. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb 01; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 15. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome.
    Jedel E, Gustafson D, Waern M, Sverrisdottir YB, Landén M, Janson PO, Labrie F, Ohlsson C, Stener-Victorin E.
    Psychoneuroendocrinology; 2011 Nov 01; 36(10):1470-9. PubMed ID: 21549510
    [Abstract] [Full Text] [Related]

  • 16. Prospective follow-up of menstrual disorders in adolescence and prognostic factors.
    Wiksten-Almströmer M, Hirschberg AL, Hagenfeldt K.
    Acta Obstet Gynecol Scand; 2008 Nov 01; 87(11):1162-8. PubMed ID: 18956264
    [Abstract] [Full Text] [Related]

  • 17. Electrical and manual acupuncture stimulation affect oestrous cyclicity and neuroendocrine function in an 5α-dihydrotestosterone-induced rat polycystic ovary syndrome model.
    Feng Y, Johansson J, Shao R, Mannerås-Holm L, Billig H, Stener-Victorin E.
    Exp Physiol; 2012 May 01; 97(5):651-62. PubMed ID: 22337865
    [Abstract] [Full Text] [Related]

  • 18. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
    Kelekci KH, Kelekci S, Incki K, Ozdemir O, Yilmaz B.
    Int J Dermatol; 2010 Jul 01; 49(7):775-9. PubMed ID: 20618496
    [Abstract] [Full Text] [Related]

  • 19. [Different types of menstrual cycle and their significance in Chinese women diagnosed with polycystic ovary syndrome according to the Rotterdam consensus criteria].
    Xu XH, Tan YC, Shi YH, Wang B, Ju XQ, Zheng QM, Hao CF, Chen ZJ.
    Zhonghua Yi Xue Za Zhi; 2009 Oct 13; 89(37):2604-6. PubMed ID: 20137675
    [Abstract] [Full Text] [Related]

  • 20. Circulating gonadotropins and ovarian adiponectin system are modulated by acupuncture independently of sex steroid or β-adrenergic action in a female hyperandrogenic rat model of polycystic ovary syndrome.
    Maliqueo M, Benrick A, Alvi A, Johansson J, Sun M, Labrie F, Ohlsson C, Stener-Victorin E.
    Mol Cell Endocrinol; 2015 Sep 05; 412():159-69. PubMed ID: 25963796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.